CA2594790A1 - Genes encoding the synthetic pathway for the production of disorazole - Google Patents
Genes encoding the synthetic pathway for the production of disorazole Download PDFInfo
- Publication number
- CA2594790A1 CA2594790A1 CA002594790A CA2594790A CA2594790A1 CA 2594790 A1 CA2594790 A1 CA 2594790A1 CA 002594790 A CA002594790 A CA 002594790A CA 2594790 A CA2594790 A CA 2594790A CA 2594790 A1 CA2594790 A1 CA 2594790A1
- Authority
- CA
- Canada
- Prior art keywords
- orf
- disorazole
- ptn
- proteins
- rec
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
Landscapes
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The present invention relates to nucleic acid sequences and proteins derivable therefrom that have been identified in Sorangium cellulosum, which proteins are catalytically active or participate in the biosynthetic pathway of disorazoles. The invention provides novel sequences which are necessary components of the disorazole biosynthetic pathway in addition to genes dszA-D.
Description
Genes encoding the synthetic pathway for the production of disorazole The present invention relates to nucleic acid sequences and proteins derivable therefrom which are catalytically active or participate in the biosynthetic pathway of disorazoles. The catalytically active proteins, i.e. enzymes, are also known as polyketide synthases and nonribosomal peptide synthetases.
It is known that myxobacteria produce a large variety of biologically active compounds, also known as secondary metabolites. Among these secondary metabolites, the group of disorazoles has attracted attention as inhibitors for the polymerisation of tubulin, for the induction of apoptosis and for the arrest of the cell cycle or inhibition of cell proliferation at concentrations as low as e.g. 3 pM. The present invention provides nucleic acid sequences and proteins which can be translated from the nucleic acid sequences into catalytically active proteins or proteins participating in the biosynthesis of disorazoles. In cooperation, these translated proteins in vivo and/or in vitro catalyze the formation of disorazoles. Accordingly, the present invention also provides a production process using the nucleic acid sequences and/or proteins derivable therefrom for the production of disorazoles, for example using homologous or heterologous expression of proteins derivable from these nucleic acid sequences in microorganisms for fermentation or the peptides in an immobilized state to produce disorazoles from precursor compounds.
State of the art WO 2004/053065 A2 describes nucleic acid sequences encoding disorazole polyketide synthases DszA, DszB, DszC and DszD obtained from Sorangium cellulosum So ce 12 using transposon generated cosmids. In very general terms, synthetic synthases are described which can be obtained by rearrangement of domains that can be identified in the wildtype disorazole synthase enzymes, namely a ketoreductase domain, a dehydratase domain, an enoylreductase domain, a ketosynthase domain, a nonribosomal protein synthetase domain, a methyltransferase domain, an acyl carrier protein domain, a serine cyclization domain, a serine condensation domain, an adenylation domain, a peptidyl carrier protein domain, a thiolation domain, an oxidase domain, a thioesterase domain, and an acyl transferase domain from a total number of 8 domains in the disorazole synthetase. These domains are predicted from the DNA sequence obtained. However, specific synthetic rearrangements of these domains are not identified. The nucleotide sequence disclosed for the disorazole polyketide synthase and/or nonribosomal peptide synthetase comprises 77294 bp and allegedly includes the coding sequences for DszA, DszB, DszC, DszD and several other open reading frames which are located adjacent one another.
The present invention relates to the group of disorazoles, namely disorazole Al and derivatives thereof, for example dizorazoles according to the following formulae 1-8 and specific embodiments of these as detailed below:
Formula 1 Formula 2 X CH3 x CH3 X H3C CH3 x H C CH3 x O O
x R2 R3 00 X N ~0 R3 00 X N 0 H3c 0 H3c ~ 0 X. R1 R1 Formula 3 Formula 4 O X O
0 R3 N 0 0 00 X N ~0 X X
Formula 5 Formula 6 O O \
R3 O O X N~O R3 O 0 X N O
H3c o H3c o X X
Formula 7 Formula 8 O ~ R2 0 ~
X O ~ X O
0 R3 X N~O R3 00 X =0 X
wherein X represents an 0, two vicinal OH, or a single bond and Rl, R2, R3, R4 each represent independently H, OH, OCH3.
Specific embodiments of general formulae 1-8 are:
Disorazole Al - A7 Disorazole F1 - F3 Disorazole B1 - B4 Disorazole G1 - G3 Disorazole Cl - C2 Disorazole H
Disorazole D1 - D5 Disorazole I
Disorazole El - E3 (R. Janssen et al., Liebigs Ann. Chem. 1994, 759-773).
It is known that myxobacteria produce a large variety of biologically active compounds, also known as secondary metabolites. Among these secondary metabolites, the group of disorazoles has attracted attention as inhibitors for the polymerisation of tubulin, for the induction of apoptosis and for the arrest of the cell cycle or inhibition of cell proliferation at concentrations as low as e.g. 3 pM. The present invention provides nucleic acid sequences and proteins which can be translated from the nucleic acid sequences into catalytically active proteins or proteins participating in the biosynthesis of disorazoles. In cooperation, these translated proteins in vivo and/or in vitro catalyze the formation of disorazoles. Accordingly, the present invention also provides a production process using the nucleic acid sequences and/or proteins derivable therefrom for the production of disorazoles, for example using homologous or heterologous expression of proteins derivable from these nucleic acid sequences in microorganisms for fermentation or the peptides in an immobilized state to produce disorazoles from precursor compounds.
State of the art WO 2004/053065 A2 describes nucleic acid sequences encoding disorazole polyketide synthases DszA, DszB, DszC and DszD obtained from Sorangium cellulosum So ce 12 using transposon generated cosmids. In very general terms, synthetic synthases are described which can be obtained by rearrangement of domains that can be identified in the wildtype disorazole synthase enzymes, namely a ketoreductase domain, a dehydratase domain, an enoylreductase domain, a ketosynthase domain, a nonribosomal protein synthetase domain, a methyltransferase domain, an acyl carrier protein domain, a serine cyclization domain, a serine condensation domain, an adenylation domain, a peptidyl carrier protein domain, a thiolation domain, an oxidase domain, a thioesterase domain, and an acyl transferase domain from a total number of 8 domains in the disorazole synthetase. These domains are predicted from the DNA sequence obtained. However, specific synthetic rearrangements of these domains are not identified. The nucleotide sequence disclosed for the disorazole polyketide synthase and/or nonribosomal peptide synthetase comprises 77294 bp and allegedly includes the coding sequences for DszA, DszB, DszC, DszD and several other open reading frames which are located adjacent one another.
The present invention relates to the group of disorazoles, namely disorazole Al and derivatives thereof, for example dizorazoles according to the following formulae 1-8 and specific embodiments of these as detailed below:
Formula 1 Formula 2 X CH3 x CH3 X H3C CH3 x H C CH3 x O O
x R2 R3 00 X N ~0 R3 00 X N 0 H3c 0 H3c ~ 0 X. R1 R1 Formula 3 Formula 4 O X O
0 R3 N 0 0 00 X N ~0 X X
Formula 5 Formula 6 O O \
R3 O O X N~O R3 O 0 X N O
H3c o H3c o X X
Formula 7 Formula 8 O ~ R2 0 ~
X O ~ X O
0 R3 X N~O R3 00 X =0 X
wherein X represents an 0, two vicinal OH, or a single bond and Rl, R2, R3, R4 each represent independently H, OH, OCH3.
Specific embodiments of general formulae 1-8 are:
Disorazole Al - A7 Disorazole F1 - F3 Disorazole B1 - B4 Disorazole G1 - G3 Disorazole Cl - C2 Disorazole H
Disorazole D1 - D5 Disorazole I
Disorazole El - E3 (R. Janssen et al., Liebigs Ann. Chem. 1994, 759-773).
General description of the invention The present invention provides the complete nucleic acid sequences encoding not only a gene cluster but further additional genetic elements which are necessary for correct biosynthesis of disorazoles. The entire biosynthetic gene cluster is disclosed, having high homology to the DszA - D disclosed in WO 2004/053065 A2 including its functional analysis.
The core biosynthetic gene cluster for the biosynthetic pathway for disorazoles comprises genes disA through disD. The gene disA is preceded by a putative ribosomal binding site located 11 base pairs upstream from the designated start codon (GTG). DisB
presumably starts with an ATG and a putative ribosomal binding site could be localized 7 base pairs upstream from the start codon. Arranged with disA and disB, which are polyketide synthases, in one transcriptional unit is disC, the latter encoding a mixed polyketide synthase /
nonribosomal peptide synthetase. DisC most likely starts with an ATG, preceded by a putative ribosomal binding site located 8 base pairs upstream. An alternative start codon of disC could be found 36 base pairs downstream of the putative start codon.
Downstream this transcriptional unit of disA, disB and disC, a probable transcription terminator is located.
Following orf 9, located downstream of the transcriptional unit disA through disC, disD was identified having its putative ribosomal binding site 7 base pairs upstream its start codon. The gene disD shows significant similarities to the bifunctional proteins LnmG
from the leinamycin biosynthetic gene cluster and to MmpIII from the mupirocin biosynthetic gene cluster. The C-terminus of DisD has close sequence similarity to the oxidoreductase superfamily. From a total of four transposon mutants, listed in Table 3 below, plasmids were recovered, harbouring the hygromycin resistance gene and the kpir dependent origin of replication (ori) R6K together with parts of chromosomal DNA of Sorangium cellulosum So ce 12 which originally flanked the transposition site. A computer assisted analysis of the chromosomal DNA portions using BLAST searches identified two of the proteins predicted from the recovered DNA portions as putative fragments of a polyketide synthase and a nonribosomal peptide synthetase. Using these two chromosomal DNA portions as probes for hybridization with a BAC library, previously established for Sorangium cellulosum So ce 12, sequencing of hybridizing BAC clones yielded orfs encoding proteins participating in the biosynthesis of disorazoles, which are summarised in Table 1 below.
Detailed description of the invention When analysing the biosynthetic pathway for the production of disorazoles, the genomic DNA of Sorangium cellulosum So ce 12 has been analyzed to identify the genes whose translation products are necessary components of the synthetic pathway, fmally producing disorazoles including known variants or derivatives of disorazole A, e. g.
according to formulae 1- 8 above. The gene cluster encoding the enzymes catalyzing the biosynthesis of disorazoles comprises the translation products of disA, disB, disC, disD. It is possible that translation products from open reading frame (orf) orf 9, arranged between disC and disD, may participate in or be beneficial to the biosynthesis of disorazoles.
In the following, reference is made to the figures, wherein = Figure 1 is a schematic representation of the synthetic pathway for disorazoles, = Figure 2 schematically shows the arrangement of genes adjacent to the insertion site of the transposon in the transposon mutant So ce 12_EXI_IE-2 and sequenced from its plasmid pTn-Rec_IE-2, and = Figure 3 lists nucleic acid and amino acid sequences relevant to the invention, namely the nucleic acid sequence ofpTn-Rec_IE-2 (Seq.-ID No. 1), the amino acid sequences of orf 1-pTn-Rec_IE-2 (Seq.-ID No. 2), orf 2-pTn-Rec_IE-2 (Seq.-ID No. 3), orf pTn-Rec_IE-2 (Seq.-ID No. 4), orf 4-pTn-Rec_IE-2 (Seq.-ID No. 5), orf 5-pTn-Rec IE-2 (Seq.-ID No. 6), the nucleic acid sequence disA-disD (Seq.-ID No. 7) comprising genes disA, disB, disC, orf 9 and disD, and amino acid sequences of DisA
(Seq.-ID No. 8), DisB (Seq.-ID No. 9), DisC (Seq.-ID No. 10), orf 9 (Seq.-ID
No. 11) and DisD (Seq.-ID No. 12).
The functions proposed in Table 1 above have been identified by a similarity search on known sequences, however, the gene products from the orfs of Table 1 can differ according to their function in the biosynthetic gene cluster for disorazoles.
An analysis of the genomic DNA region encoding disA through disD has revealed several orfs in the vicinity of disA through disD, summarised in Table 1.
Table 1: Orfs identified in the biosynthetic gene cluster for disorazoles Acc.
Orienta- Proposed Function No. of Size tion of the Similar Similarity to Similarity/ similar Gene (Da/bp) (strand) Protein Source Identity protein orfl 49316/ - b1r4832 Bradyrhizobium 49%/67%, NC 00 1374 Sugar (and other) japonicum USDA 4463.1 transporter 110 orf2 51696/ - probable two- Pseudomonas 49%/66% NC 00 1449 component aeruginosa PAO1 2516.1 response regulator, signal receiver domain orf3 45545/ + hypothetical Leptospira 27%/40% NC 00 1293 protein interrogans 4342.1 serovar Lai str.
orf4 56119/ - no prediction orf5 48994/ - probable two- Pseudomonas 51%/69% NC 00 1371 component aeruginosa PAO1 2516.1 response regulator, signal receiver domain orf6 105961 - sensory box Pseudomonas 39%/55% NC 00 /3021 histidine kinase putida KT2440 2947.3 orfl 34954/ - phosphotransferase Escherichia coli 29%/40% 4~5 orf$ 37435/ + putative Streptomyces 33%/48% NC 00 1053 serine/threonine avermitilis MA- 3155.2 protein kinase 4680 disA +
-C
orf9 30717/ + no functional 822 prediction disD +
orf 23476/ - phosphotransferase Bacillus subtilis 38%/56% NC 00 642 subsp. subtilis str. 0964.2 orf 46773/ + putative sugar Streptomyces 27%/41% NC 00 11 1287 transporter avermitilis MA- 3155.2 orf 32992/ + ABC membrane Brevibacterium 36%/53% 093RD
12 912 transporter fuscum var. 7 homologue dextranlyticum orf 31993/ + ABC membrane Brevibacterium 51o/a/72o/a 093RD
13 882 transporter fuscum var. 6 homologue dextranlyticum Table 1 continued:
orf 86590/ + putative sugar Streptomyces 61 %/72% NP_73 14 2355 hydrolase coelicolor A3(2) 3521 orf 105005 + putative sugar Streptomyces 46%/59% NP_62 15 /2892 hydrolase coelicolor A3(2) 9813 orf 121293 + serine-threonine Mycobacterium 36%/53% NP_30 16 /3273 protein kinase leprae TN 1681 orf 23384/ - no prediction orf 35402/ - no prediction orf 25075/ - no prediction Figure 1 schematically depicts the arrangement of genes disA, disB, disC, orf9, and disD, wherein the abbreviations refer to catalytic centers and domains as follows:
Dark shade : polyketide synthase (PKS), Light shade nonribosomal protein synthetase (NRPS), KS: ketosynthase, DH: 0-hydroxydehydratase, KR: 0-ketoacyl reductase, ACP: acyl carrier protein, MT: methyltransferase, HC:
heterocyclization domain, A: adenylation domain, PCP: peptidyl carrier protein, Ox: oxidation domain, TE: thioesterase domain, AT: acyl transferase, Or: oxidoreductase, and 1: site of insertion of transposon in different mutants.
The sites indicated by the arrows (1) are designated as So12_EX_13-21 and So12_EX 2793, which are So ce 12 mutants from which the plasmids pTn-Rec13-21 and pTn-Rec2793, respectively, were recovered.
The arrangement of genes adjacent to the insertion site of the transposon mutant So ce 12_EXI IE-2 is schematically depicted in Figure 2.
For the gene products of disA through disD, functions can be proposed for individual protein domains by homology search. These proposed functions, including their relative positions in the individual nucleic acid sequences are listed in Table 2 below.
Table 2: Disorazole biosynthetic genes disA, disB, disC and disD
Proposed Function Protein Size (Protein domains with their positions in the amino acid sequences of (Gene) (Da/bp) Figure 3) DisA 647772/ PKS Domains: KS1 (3-428), DH1 (953-1144), KR1(1528-1779), (disA) 18036 ACP1 (1821-1889), KS2 (1971-2395); KR2 (2856-3105), MT2 (3225-3463), ACP2 (3537-3606), ACP2b (3672-3741), KS3 (3779-4201), KR3 (4642-4898), ACP3 (4918-4987), KS4 (5059-5490), DH4 (5649-5878) DisB 672408/ PKS Domains: KR4 (238-492), ACP4 (547-615), KS5 (676-1114), (disB) 18771 DH5 (1274-1476), KR5 (1836-2093), ACP5 (2108-2176), KS6 (2255-2686), DH6 (2944-3149), KR6 (3490-3738), ACP6 (3776-3824), KS7 (3876-4304), DH7 (4472-4679), KR7 (5049-5302),ACP7 (5316-5398), KS8 (5500-5926), ACP8 (6123-6192) DisC 409960/ NRPS Domains:HC1a (58-506), HC1b (532-955), Al (1035-1551), (disC) 11379 PCP1 (1580-1647), OX (1649-1836), PKS Domains: KS9 (1882-2309), ACP9 (2542-2609), KS10 (2668-3098), ACP10 (3399-3468), TE (3521-3701) DisD 90953/ PKS-Domains: AT (1-280), OX (393-839) (disD) 2526 Abbreviations are according to Figure 1.
However, when analysing the synthesis of disorazoles in microorganisms expressing the biosynthetic gene cluster consisting of the sequences encoding DisA, DisB, DisC and DisD
only, homologous sequences of which have been described in WO 2004/053065 A2, it is considered impossible that the full range of derivative disorazoles could be produced with the translation products DisA, DisB, DisC and DisD only. The reason is that comparative analysis showed that DisA, DisB, DisC and DisD lack at least some functions, e.g.
necessary for hydroxylation, epoxidation and methoxylation, that are assumed necessary for synthesis of at least some known derivatives of disorazole.
Further analysis of the genomic region adjacent the genes disA through disD, for example the gene products of those orfs listed in Table 2 above, did not identify coding sequences for accessory functions to complement the biosynthetic pathway of DisA through DisD to allow production of disorazole or the range of known disorazole derivatives.
Analysis of the two additional disorazole negative mutants revealed further sequences obtainable from Sorangium cellulosum So ce 12, at least one of which encodes a translation product that is necessary for synthesis of disorazoles in combination with the translation products of disA, disB, disC and disD, preferably in combination with the translation product of orf 9. These additional nucleic acid sequences have been identified on recovered plasmids of disorazole negative So ce 12 mutants and are summarised in Table 3 below.
Table 3: Recovered plasmids and proposed function of the encoded proteins Identity/
Plasmid Proposed function of the similar Source of the Similarity protein similar protein (DNA/
protein) pTn-Rec_2793 BarG (PKS) Lyngbya majuscula barbamide biosynthetic gene cluster 39%/57%
pTn-Rec_13-3 5' to transposition site: no prediction Rhodopirellula 3' to transposition site: baltica SH 1 28%/45%
carbamoyltransferase B1mD
pTn-Rec_13-21 LnmJ (PKS) Streptomyces leinamycin biosynthetic gene cluster atroolivaceus 29%/40%
pTn-Rec_IE-2 beta-lactamase Oceanobacillus iheyensis 38%/53%
putative esterase Rhodopirellula 30%/48%
baltica SH 1 The proposed functions have been identified by similarity searches with known proteins but may be different from the proposed functions indicated here according to their functions within the biosynthetic gene pathway.
Sequencing of pTn-Rec_IE-2 identified a total of 5 orfs and their putative functions, which are summarized in Table 4 below:
Table 4: Proteins encoded on the plasmid pTn-RecIE-2 and their putative function Position Size Proposed Source Similarity/
orf on DNA (Da/bp) Function Identity sequence of the Similar (DNA/
of pTn- Protein protein) RecIE-2 orf 1- 58 - 579 18008/522 arylesterase- Caulobacter 29%/43%
pTn- related protein crescentus RecIE-2 orf 2 - 1665 - 20979/591 SAM-dependent Gloeobacter 48%/58%
pTn- 2255 methyl- violaceus RecIE-2 transferase orf 3 - 3159 - 46369/128 putative esterase Rhodopirellula 35%/51%
pTn- 4442 4 beta-lactamase baltica SH 1 RecIE-2 Oceanobacillus iheyensis orf 4 - 4459 - 62063/178 adenylate cyclase Stigmatella 31 %/51 %
pTn- 6240 2 2 aurantiaca RecIE-2 orf 5 - 6328 - 29564/854 outer membrane Myxococcus 36%/46 pTn- 7181 protein xanthus RecIE-2 (incomplete) In a first embodiment of the present invention, at least one of the translation products of Table 4 is used in combination with the translation products of disA through disD to provide the biosynthetic pathway for disorazoles, in a preferred embodiment, at least 2, more preferred three or four translation products of the sequences identified in Table 4 participate in the biosynthetic pathway for disorazoles in combination with disA through disD, preferably including the translation product of orf 9.
The DNA sequences of disA, disB, disC, disD and orf 1-pTn-Rec_IE-2, orf 2-pTn-Rec_IE-2, orf 3-pTn-Rec_IE-2, orf 4-pTn-Rec_IE-2, and orf 5-pTn-Rec_IE-2 as well as their translation products obtained from Sorangium cellulosum So ce 12 are listed in Figure 3.
These specific sequences are preferred for performing the present invention, but other coding sequences and peptides derivable therefrom providing the respective activity necessary in the disorazole synthetic pathway are also applicable in the present invention and can replace the sequences of Figure 3.
The present invention will now be described in greater detail by way of examples, which are not intended to limit the scope of the invention.
Example 1: Cloning and sequencing of nucleic acid sequences complementing the biosynthetic pathway enzymes for disorazoles Nucleic acid sequences, the translation products of which participate in the biosynthetic pathway for disorazoles have been identified using a transposon recovery procedure from disorazole negative transposon mutants of Sorangium cellulosum strain So ce 12. Strain So ce 12 is available at NCIMB Aberdeen, UK, under accession No. NCIB 12134.
For transposon mutagenesis, transposon termed pMiniHimarHyg which is applicable to myxobacteria was used, comprising the hygromycin resistance, but lacking the genes for conjugational DNA transfer. The transformation of Sorangium cellulosum was obtained by electroporation as described in European patent application EP 04 103 546.0, filed on 23 July 2004 with the European patent office.
Disorazole negative mutants were detected in a bioassay using an overlay with the disorazole sensitive yeast R. glutinis. In this bioassay, transposon mutants were plated on PM 12 agar plates without hygromycin at 32 C until colonies became visible, then overlayed with R.
glutinis, incubated overnight at 30 C and growth inhibition zones were compared to a wild type Sorangium cellulosum So ce 12.
Transposon recovery from disorazole negative transposon mutant colonies was essentially carried out as described in Kopp et al. (J. Biotech 107, 29 (2004)) Example 2: Heterolo opression of biosynthetic pathway enzymes for the production of disorazole The core biosynthetic gene cluster and their respective translation products sufficient for the biosynthesis of disorazoles was determined by heterologous gene expression experiments. As expected, the core enzymes comprising disA, disB, disC as well as disD are regarded as necessary components for the biosynthetic pathway. An optional and preferably included component is orf 9.
The core cluster comprising disA, disB, disC as well as disD needs complementation with at least an expression cassette encoding orf 3-pTn-Rec_IE-2, optionally in combination with orf 1-pTn-Rec_IE-2, optionally in combination with orf 2-pTn-Rec_IE-2, optionally in combination with orf 4-pTn-Rec_IE-2, and optionally in combination with orf 5-pTn-Rec_IE-2.
When expressing sequences encoding at least one, preferably two, more preferably three or four and most preferably all of the group comprising orf 1-pTn-Rec_IE-2, orf 2-pTn-Rec_IE-2, orf 4-pTn-Rec_IE-2, and orf 5-pTn-Rec_IE-2, in combination with orf 3 - pTn-Rec_IE-2 to supplement the expression cassettes encoding disA - disD, optionally orf 9, respectively, production of disorazoles was found.
The number of derivative disorazoles varied according to the sequences selected among orf 1-pTn-Rec_IE-2, orf 2-pTn-Rec_IE-2, orf 4-pTn-Rec_IE-2, and orf 5-pTn-Rec_IE-2 for expression in combination with orf 3 - pTn-Rec_IE-2 and disA - disD, optionally orf 9. It is preferred that the coding sequences are contained intra-chromosomally in their natural arrangement.
For production of disorazoles, the identification of the set of genes or gene cluster according to the invention allows to modify producer strains, for example by specifically targeted modification of regulatory elements, e.g. the introduction of stronger promoters for disA, disB, disC, orf 9, and/or disD, and/or for the complementing genes orf 1-pTn-Rec_IE-2, orf 2-pTn-Rec_IE-2, orf 3 - pTn-Rec_IE-2, orf 4-pTn-Rec_IE-2, and/or orf 5-pTn-Rec_IE-2.
Alternatively, heterologous expression can be employed using microorganisms which are no natural producers of disorazole. For heterologous expression, Myxococcales, preferably Myxococcus xanthus, or Polyangium, also termed Sorangium, e. g. Sorangium cellulosum accessible as ATCC 25531, ATCC 29479 (DSMZ 2044), Stigmatella aurantiaca, Angiococcus disciforrnis and strains of the genus Pseudomonas, e.g.
Pseudomonasputida, Pseudomonas stutzeri, and Pseudomonas syringae can be used.
Alternatively, the expression products, i. e. proteins derivable from the aforementioned sets of genes for the synthetic pathway, can be used in an extracellular synthesis system, e. g. as catalysts like an immobilized enzyme system for synthesis of disorazoles.
The core biosynthetic gene cluster for the biosynthetic pathway for disorazoles comprises genes disA through disD. The gene disA is preceded by a putative ribosomal binding site located 11 base pairs upstream from the designated start codon (GTG). DisB
presumably starts with an ATG and a putative ribosomal binding site could be localized 7 base pairs upstream from the start codon. Arranged with disA and disB, which are polyketide synthases, in one transcriptional unit is disC, the latter encoding a mixed polyketide synthase /
nonribosomal peptide synthetase. DisC most likely starts with an ATG, preceded by a putative ribosomal binding site located 8 base pairs upstream. An alternative start codon of disC could be found 36 base pairs downstream of the putative start codon.
Downstream this transcriptional unit of disA, disB and disC, a probable transcription terminator is located.
Following orf 9, located downstream of the transcriptional unit disA through disC, disD was identified having its putative ribosomal binding site 7 base pairs upstream its start codon. The gene disD shows significant similarities to the bifunctional proteins LnmG
from the leinamycin biosynthetic gene cluster and to MmpIII from the mupirocin biosynthetic gene cluster. The C-terminus of DisD has close sequence similarity to the oxidoreductase superfamily. From a total of four transposon mutants, listed in Table 3 below, plasmids were recovered, harbouring the hygromycin resistance gene and the kpir dependent origin of replication (ori) R6K together with parts of chromosomal DNA of Sorangium cellulosum So ce 12 which originally flanked the transposition site. A computer assisted analysis of the chromosomal DNA portions using BLAST searches identified two of the proteins predicted from the recovered DNA portions as putative fragments of a polyketide synthase and a nonribosomal peptide synthetase. Using these two chromosomal DNA portions as probes for hybridization with a BAC library, previously established for Sorangium cellulosum So ce 12, sequencing of hybridizing BAC clones yielded orfs encoding proteins participating in the biosynthesis of disorazoles, which are summarised in Table 1 below.
Detailed description of the invention When analysing the biosynthetic pathway for the production of disorazoles, the genomic DNA of Sorangium cellulosum So ce 12 has been analyzed to identify the genes whose translation products are necessary components of the synthetic pathway, fmally producing disorazoles including known variants or derivatives of disorazole A, e. g.
according to formulae 1- 8 above. The gene cluster encoding the enzymes catalyzing the biosynthesis of disorazoles comprises the translation products of disA, disB, disC, disD. It is possible that translation products from open reading frame (orf) orf 9, arranged between disC and disD, may participate in or be beneficial to the biosynthesis of disorazoles.
In the following, reference is made to the figures, wherein = Figure 1 is a schematic representation of the synthetic pathway for disorazoles, = Figure 2 schematically shows the arrangement of genes adjacent to the insertion site of the transposon in the transposon mutant So ce 12_EXI_IE-2 and sequenced from its plasmid pTn-Rec_IE-2, and = Figure 3 lists nucleic acid and amino acid sequences relevant to the invention, namely the nucleic acid sequence ofpTn-Rec_IE-2 (Seq.-ID No. 1), the amino acid sequences of orf 1-pTn-Rec_IE-2 (Seq.-ID No. 2), orf 2-pTn-Rec_IE-2 (Seq.-ID No. 3), orf pTn-Rec_IE-2 (Seq.-ID No. 4), orf 4-pTn-Rec_IE-2 (Seq.-ID No. 5), orf 5-pTn-Rec IE-2 (Seq.-ID No. 6), the nucleic acid sequence disA-disD (Seq.-ID No. 7) comprising genes disA, disB, disC, orf 9 and disD, and amino acid sequences of DisA
(Seq.-ID No. 8), DisB (Seq.-ID No. 9), DisC (Seq.-ID No. 10), orf 9 (Seq.-ID
No. 11) and DisD (Seq.-ID No. 12).
The functions proposed in Table 1 above have been identified by a similarity search on known sequences, however, the gene products from the orfs of Table 1 can differ according to their function in the biosynthetic gene cluster for disorazoles.
An analysis of the genomic DNA region encoding disA through disD has revealed several orfs in the vicinity of disA through disD, summarised in Table 1.
Table 1: Orfs identified in the biosynthetic gene cluster for disorazoles Acc.
Orienta- Proposed Function No. of Size tion of the Similar Similarity to Similarity/ similar Gene (Da/bp) (strand) Protein Source Identity protein orfl 49316/ - b1r4832 Bradyrhizobium 49%/67%, NC 00 1374 Sugar (and other) japonicum USDA 4463.1 transporter 110 orf2 51696/ - probable two- Pseudomonas 49%/66% NC 00 1449 component aeruginosa PAO1 2516.1 response regulator, signal receiver domain orf3 45545/ + hypothetical Leptospira 27%/40% NC 00 1293 protein interrogans 4342.1 serovar Lai str.
orf4 56119/ - no prediction orf5 48994/ - probable two- Pseudomonas 51%/69% NC 00 1371 component aeruginosa PAO1 2516.1 response regulator, signal receiver domain orf6 105961 - sensory box Pseudomonas 39%/55% NC 00 /3021 histidine kinase putida KT2440 2947.3 orfl 34954/ - phosphotransferase Escherichia coli 29%/40% 4~5 orf$ 37435/ + putative Streptomyces 33%/48% NC 00 1053 serine/threonine avermitilis MA- 3155.2 protein kinase 4680 disA +
-C
orf9 30717/ + no functional 822 prediction disD +
orf 23476/ - phosphotransferase Bacillus subtilis 38%/56% NC 00 642 subsp. subtilis str. 0964.2 orf 46773/ + putative sugar Streptomyces 27%/41% NC 00 11 1287 transporter avermitilis MA- 3155.2 orf 32992/ + ABC membrane Brevibacterium 36%/53% 093RD
12 912 transporter fuscum var. 7 homologue dextranlyticum orf 31993/ + ABC membrane Brevibacterium 51o/a/72o/a 093RD
13 882 transporter fuscum var. 6 homologue dextranlyticum Table 1 continued:
orf 86590/ + putative sugar Streptomyces 61 %/72% NP_73 14 2355 hydrolase coelicolor A3(2) 3521 orf 105005 + putative sugar Streptomyces 46%/59% NP_62 15 /2892 hydrolase coelicolor A3(2) 9813 orf 121293 + serine-threonine Mycobacterium 36%/53% NP_30 16 /3273 protein kinase leprae TN 1681 orf 23384/ - no prediction orf 35402/ - no prediction orf 25075/ - no prediction Figure 1 schematically depicts the arrangement of genes disA, disB, disC, orf9, and disD, wherein the abbreviations refer to catalytic centers and domains as follows:
Dark shade : polyketide synthase (PKS), Light shade nonribosomal protein synthetase (NRPS), KS: ketosynthase, DH: 0-hydroxydehydratase, KR: 0-ketoacyl reductase, ACP: acyl carrier protein, MT: methyltransferase, HC:
heterocyclization domain, A: adenylation domain, PCP: peptidyl carrier protein, Ox: oxidation domain, TE: thioesterase domain, AT: acyl transferase, Or: oxidoreductase, and 1: site of insertion of transposon in different mutants.
The sites indicated by the arrows (1) are designated as So12_EX_13-21 and So12_EX 2793, which are So ce 12 mutants from which the plasmids pTn-Rec13-21 and pTn-Rec2793, respectively, were recovered.
The arrangement of genes adjacent to the insertion site of the transposon mutant So ce 12_EXI IE-2 is schematically depicted in Figure 2.
For the gene products of disA through disD, functions can be proposed for individual protein domains by homology search. These proposed functions, including their relative positions in the individual nucleic acid sequences are listed in Table 2 below.
Table 2: Disorazole biosynthetic genes disA, disB, disC and disD
Proposed Function Protein Size (Protein domains with their positions in the amino acid sequences of (Gene) (Da/bp) Figure 3) DisA 647772/ PKS Domains: KS1 (3-428), DH1 (953-1144), KR1(1528-1779), (disA) 18036 ACP1 (1821-1889), KS2 (1971-2395); KR2 (2856-3105), MT2 (3225-3463), ACP2 (3537-3606), ACP2b (3672-3741), KS3 (3779-4201), KR3 (4642-4898), ACP3 (4918-4987), KS4 (5059-5490), DH4 (5649-5878) DisB 672408/ PKS Domains: KR4 (238-492), ACP4 (547-615), KS5 (676-1114), (disB) 18771 DH5 (1274-1476), KR5 (1836-2093), ACP5 (2108-2176), KS6 (2255-2686), DH6 (2944-3149), KR6 (3490-3738), ACP6 (3776-3824), KS7 (3876-4304), DH7 (4472-4679), KR7 (5049-5302),ACP7 (5316-5398), KS8 (5500-5926), ACP8 (6123-6192) DisC 409960/ NRPS Domains:HC1a (58-506), HC1b (532-955), Al (1035-1551), (disC) 11379 PCP1 (1580-1647), OX (1649-1836), PKS Domains: KS9 (1882-2309), ACP9 (2542-2609), KS10 (2668-3098), ACP10 (3399-3468), TE (3521-3701) DisD 90953/ PKS-Domains: AT (1-280), OX (393-839) (disD) 2526 Abbreviations are according to Figure 1.
However, when analysing the synthesis of disorazoles in microorganisms expressing the biosynthetic gene cluster consisting of the sequences encoding DisA, DisB, DisC and DisD
only, homologous sequences of which have been described in WO 2004/053065 A2, it is considered impossible that the full range of derivative disorazoles could be produced with the translation products DisA, DisB, DisC and DisD only. The reason is that comparative analysis showed that DisA, DisB, DisC and DisD lack at least some functions, e.g.
necessary for hydroxylation, epoxidation and methoxylation, that are assumed necessary for synthesis of at least some known derivatives of disorazole.
Further analysis of the genomic region adjacent the genes disA through disD, for example the gene products of those orfs listed in Table 2 above, did not identify coding sequences for accessory functions to complement the biosynthetic pathway of DisA through DisD to allow production of disorazole or the range of known disorazole derivatives.
Analysis of the two additional disorazole negative mutants revealed further sequences obtainable from Sorangium cellulosum So ce 12, at least one of which encodes a translation product that is necessary for synthesis of disorazoles in combination with the translation products of disA, disB, disC and disD, preferably in combination with the translation product of orf 9. These additional nucleic acid sequences have been identified on recovered plasmids of disorazole negative So ce 12 mutants and are summarised in Table 3 below.
Table 3: Recovered plasmids and proposed function of the encoded proteins Identity/
Plasmid Proposed function of the similar Source of the Similarity protein similar protein (DNA/
protein) pTn-Rec_2793 BarG (PKS) Lyngbya majuscula barbamide biosynthetic gene cluster 39%/57%
pTn-Rec_13-3 5' to transposition site: no prediction Rhodopirellula 3' to transposition site: baltica SH 1 28%/45%
carbamoyltransferase B1mD
pTn-Rec_13-21 LnmJ (PKS) Streptomyces leinamycin biosynthetic gene cluster atroolivaceus 29%/40%
pTn-Rec_IE-2 beta-lactamase Oceanobacillus iheyensis 38%/53%
putative esterase Rhodopirellula 30%/48%
baltica SH 1 The proposed functions have been identified by similarity searches with known proteins but may be different from the proposed functions indicated here according to their functions within the biosynthetic gene pathway.
Sequencing of pTn-Rec_IE-2 identified a total of 5 orfs and their putative functions, which are summarized in Table 4 below:
Table 4: Proteins encoded on the plasmid pTn-RecIE-2 and their putative function Position Size Proposed Source Similarity/
orf on DNA (Da/bp) Function Identity sequence of the Similar (DNA/
of pTn- Protein protein) RecIE-2 orf 1- 58 - 579 18008/522 arylesterase- Caulobacter 29%/43%
pTn- related protein crescentus RecIE-2 orf 2 - 1665 - 20979/591 SAM-dependent Gloeobacter 48%/58%
pTn- 2255 methyl- violaceus RecIE-2 transferase orf 3 - 3159 - 46369/128 putative esterase Rhodopirellula 35%/51%
pTn- 4442 4 beta-lactamase baltica SH 1 RecIE-2 Oceanobacillus iheyensis orf 4 - 4459 - 62063/178 adenylate cyclase Stigmatella 31 %/51 %
pTn- 6240 2 2 aurantiaca RecIE-2 orf 5 - 6328 - 29564/854 outer membrane Myxococcus 36%/46 pTn- 7181 protein xanthus RecIE-2 (incomplete) In a first embodiment of the present invention, at least one of the translation products of Table 4 is used in combination with the translation products of disA through disD to provide the biosynthetic pathway for disorazoles, in a preferred embodiment, at least 2, more preferred three or four translation products of the sequences identified in Table 4 participate in the biosynthetic pathway for disorazoles in combination with disA through disD, preferably including the translation product of orf 9.
The DNA sequences of disA, disB, disC, disD and orf 1-pTn-Rec_IE-2, orf 2-pTn-Rec_IE-2, orf 3-pTn-Rec_IE-2, orf 4-pTn-Rec_IE-2, and orf 5-pTn-Rec_IE-2 as well as their translation products obtained from Sorangium cellulosum So ce 12 are listed in Figure 3.
These specific sequences are preferred for performing the present invention, but other coding sequences and peptides derivable therefrom providing the respective activity necessary in the disorazole synthetic pathway are also applicable in the present invention and can replace the sequences of Figure 3.
The present invention will now be described in greater detail by way of examples, which are not intended to limit the scope of the invention.
Example 1: Cloning and sequencing of nucleic acid sequences complementing the biosynthetic pathway enzymes for disorazoles Nucleic acid sequences, the translation products of which participate in the biosynthetic pathway for disorazoles have been identified using a transposon recovery procedure from disorazole negative transposon mutants of Sorangium cellulosum strain So ce 12. Strain So ce 12 is available at NCIMB Aberdeen, UK, under accession No. NCIB 12134.
For transposon mutagenesis, transposon termed pMiniHimarHyg which is applicable to myxobacteria was used, comprising the hygromycin resistance, but lacking the genes for conjugational DNA transfer. The transformation of Sorangium cellulosum was obtained by electroporation as described in European patent application EP 04 103 546.0, filed on 23 July 2004 with the European patent office.
Disorazole negative mutants were detected in a bioassay using an overlay with the disorazole sensitive yeast R. glutinis. In this bioassay, transposon mutants were plated on PM 12 agar plates without hygromycin at 32 C until colonies became visible, then overlayed with R.
glutinis, incubated overnight at 30 C and growth inhibition zones were compared to a wild type Sorangium cellulosum So ce 12.
Transposon recovery from disorazole negative transposon mutant colonies was essentially carried out as described in Kopp et al. (J. Biotech 107, 29 (2004)) Example 2: Heterolo opression of biosynthetic pathway enzymes for the production of disorazole The core biosynthetic gene cluster and their respective translation products sufficient for the biosynthesis of disorazoles was determined by heterologous gene expression experiments. As expected, the core enzymes comprising disA, disB, disC as well as disD are regarded as necessary components for the biosynthetic pathway. An optional and preferably included component is orf 9.
The core cluster comprising disA, disB, disC as well as disD needs complementation with at least an expression cassette encoding orf 3-pTn-Rec_IE-2, optionally in combination with orf 1-pTn-Rec_IE-2, optionally in combination with orf 2-pTn-Rec_IE-2, optionally in combination with orf 4-pTn-Rec_IE-2, and optionally in combination with orf 5-pTn-Rec_IE-2.
When expressing sequences encoding at least one, preferably two, more preferably three or four and most preferably all of the group comprising orf 1-pTn-Rec_IE-2, orf 2-pTn-Rec_IE-2, orf 4-pTn-Rec_IE-2, and orf 5-pTn-Rec_IE-2, in combination with orf 3 - pTn-Rec_IE-2 to supplement the expression cassettes encoding disA - disD, optionally orf 9, respectively, production of disorazoles was found.
The number of derivative disorazoles varied according to the sequences selected among orf 1-pTn-Rec_IE-2, orf 2-pTn-Rec_IE-2, orf 4-pTn-Rec_IE-2, and orf 5-pTn-Rec_IE-2 for expression in combination with orf 3 - pTn-Rec_IE-2 and disA - disD, optionally orf 9. It is preferred that the coding sequences are contained intra-chromosomally in their natural arrangement.
For production of disorazoles, the identification of the set of genes or gene cluster according to the invention allows to modify producer strains, for example by specifically targeted modification of regulatory elements, e.g. the introduction of stronger promoters for disA, disB, disC, orf 9, and/or disD, and/or for the complementing genes orf 1-pTn-Rec_IE-2, orf 2-pTn-Rec_IE-2, orf 3 - pTn-Rec_IE-2, orf 4-pTn-Rec_IE-2, and/or orf 5-pTn-Rec_IE-2.
Alternatively, heterologous expression can be employed using microorganisms which are no natural producers of disorazole. For heterologous expression, Myxococcales, preferably Myxococcus xanthus, or Polyangium, also termed Sorangium, e. g. Sorangium cellulosum accessible as ATCC 25531, ATCC 29479 (DSMZ 2044), Stigmatella aurantiaca, Angiococcus disciforrnis and strains of the genus Pseudomonas, e.g.
Pseudomonasputida, Pseudomonas stutzeri, and Pseudomonas syringae can be used.
Alternatively, the expression products, i. e. proteins derivable from the aforementioned sets of genes for the synthetic pathway, can be used in an extracellular synthesis system, e. g. as catalysts like an immobilized enzyme system for synthesis of disorazoles.
Claims (7)
1. Proteins for the synthesis of a polyketide, said proteins having the activity of translation products encoded by the genes disA, disB, disC and disD obtainable from Sorangium cellulosum in combination with a translation product encoded by orf pTnRec_IE-2, obtainable from Sorangium cellulosum.
2. Proteins according to claim 1, characterized by the activity of at least one translation product encoded by one of orf 1- pTnRec_IE-2, orf 2- pTnRec_IE-2, orf 4-pTnRec_IE-2, and orf 5 - pTnRec_IE-2, obtainable from Sorangium cellulosum.
3. Proteins according to claim 1 or 2, characterized in that the polyketide is disorazole A1 or a derivative thereof.
4. Nucleic acid sequence, encoding a protein according to one of the preceding claims.
5. Genetically manipulated microorganism, comprising nucleic acid sequences encoding proteins according to claims 1 to 3.
6. Genetically manipulated microorganism according to claim 5, selected from Myxococcales, Sorangium or Pseudomonas.
7. Process for producing polyketides, characterized by using proteins according to one of claims 1 to 3 or a nucleic acid sequence according to claim 4 or a microorganism according one of claims 5 to 6.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05100190 | 2005-01-13 | ||
| EP05100190.7 | 2005-01-13 | ||
| PCT/EP2006/050169 WO2006075013A1 (en) | 2005-01-13 | 2006-01-12 | Genes encoding the synthetic pathway for the production of disorazole |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2594790A1 true CA2594790A1 (en) | 2006-07-20 |
Family
ID=36218522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002594790A Abandoned CA2594790A1 (en) | 2005-01-13 | 2006-01-12 | Genes encoding the synthetic pathway for the production of disorazole |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1838848A1 (en) |
| JP (1) | JP2008526246A (en) |
| CN (1) | CN101142313A (en) |
| CA (1) | CA2594790A1 (en) |
| NO (1) | NO20073619L (en) |
| TW (1) | TW200637913A (en) |
| WO (1) | WO2006075013A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1900742A1 (en) | 2006-09-07 | 2008-03-19 | AEterna Zentaris GmbH | Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof |
| CN108048472B (en) * | 2017-12-18 | 2020-12-04 | 山东大学 | Engineering strain for high-efficiency heterologous expression of Disorazole Z, gene cluster for constructing strain and application of gene cluster |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004053065A2 (en) * | 2002-12-06 | 2004-06-24 | Kosan Biosciences, Inc. | Disorazole polyketide synthase encoding polynucleotides |
-
2006
- 2006-01-12 WO PCT/EP2006/050169 patent/WO2006075013A1/en active Application Filing
- 2006-01-12 JP JP2007550791A patent/JP2008526246A/en active Pending
- 2006-01-12 CN CNA200680008184XA patent/CN101142313A/en active Pending
- 2006-01-12 EP EP06707705A patent/EP1838848A1/en not_active Withdrawn
- 2006-01-12 CA CA002594790A patent/CA2594790A1/en not_active Abandoned
- 2006-01-12 TW TW095101196A patent/TW200637913A/en unknown
-
2007
- 2007-07-13 NO NO20073619A patent/NO20073619L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TW200637913A (en) | 2006-11-01 |
| EP1838848A1 (en) | 2007-10-03 |
| JP2008526246A (en) | 2008-07-24 |
| NO20073619L (en) | 2007-10-05 |
| WO2006075013A1 (en) | 2006-07-20 |
| CN101142313A (en) | 2008-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rachid et al. | Molecular and biochemical studies of chondramide formation—highly cytotoxic natural products from Chondromyces crocatus Cm c5 | |
| Kopp et al. | Production of the tubulin destabilizer disorazol in Sorangium cellulosum: biosynthetic machinery and regulatory genes | |
| Weinig et al. | Melithiazol biosynthesis: further insights into myxobacterial PKS/NRPS systems and evidence for a new subclass of methyl transferases | |
| EP2342335B1 (en) | Novel gene cluster | |
| Nishizawa et al. | Polyketide synthase gene coupled to the peptide synthetase module involved in the biosynthesis of the cyclic heptapeptide microcystin | |
| Liu et al. | The neocarzinostatin biosynthetic gene cluster from Streptomyces carzinostaticus ATCC 15944 involving two iterative type I polyketide synthases | |
| JP4599357B2 (en) | DNA encoding a polypeptide involved in the biosynthesis of pladienolide | |
| Sucipto et al. | Exploring Chemical Diversity of α‐Pyrone Antibiotics: Molecular Basis of Myxopyronin Biosynthesis | |
| Zirkle et al. | Heterologous production of the antifungal polyketide antibiotic soraphen A of Sorangium cellulosum So ce26 in Streptomyces lividans | |
| Frank et al. | From genetic diversity to metabolic unity: studies on the biosynthesis of aurafurones and aurafuron-like structures in myxobacteria and streptomycetes | |
| Jungmann et al. | Two of a Kind The Biosynthetic Pathways of Chlorotonil and Anthracimycin | |
| Otsuka et al. | Cloning, sequencing, and functional analysis of an iterative type I polyketide synthase gene cluster for biosynthesis of the antitumor chlorinated polyenone neocarzilin in “Streptomyces carzinostaticus” | |
| US7452693B2 (en) | Discrete acyltransferases associated with type I polyketide synthases and methods of use | |
| Li et al. | Analysis of the indanomycin biosynthetic gene cluster from Streptomyces antibioticus NRRL 8167 | |
| Wenzel et al. | A type I/type III polyketide synthase hybrid biosynthetic pathway for the structurally unique ansa compound kendomycin | |
| CA2594790A1 (en) | Genes encoding the synthetic pathway for the production of disorazole | |
| RU2385935C2 (en) | Gene cluster involves in biosynthesis of safracin and application thereof in genetic engineering | |
| US8188245B2 (en) | Enduracidin biosynthetic gene cluster from streptomyces fungicidicus | |
| US20060199252A1 (en) | Genes encoding the synthetic pathway for the production of disorazole | |
| US6927286B1 (en) | Bleomycin gene cluster components and their uses | |
| US9394553B2 (en) | Biosynthetic gene cluster for chejuenolide of marine microorganism Hahella chejuensis | |
| US7364877B2 (en) | Polynucleotides encoding disorazole polyketide synthase polypeptides | |
| Boakes et al. | A new modular polyketide synthase in the erythromycin producer Saccharopolyspora erythraea | |
| CA2391131C (en) | Genes and proteins for rosaramicin biosynthesis | |
| EP2247740B1 (en) | Genes encoding the biosynthetic pathway for etnangien production |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued | ||
| FZDE | Discontinued |
Effective date: 20100112 |
|
| FZDE | Discontinued |
Effective date: 20100112 |